Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Global Medical REIT Inc (NY: GMRE )

9.290 +0.070 (+0.76%)
Official Closing Price Updated: 7:00 PM EDT, Aug 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 151,694
Open 9.250
Bid (Size) 9.060 (1)
Ask (Size) 9.420 (1)
Prev. Close 9.220
Today's Range 9.200 - 9.310
52wk Range 7.980 - 11.59
Shares Outstanding 65,587,648
Dividend Yield 9.04%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GMRE Stock Earnings: Global Medical REIT Beats EPS, Misses Revenue for Q2 2024
GMRE stock results show that Global Medical REIT beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Global Medical REIT Announces Second Quarter 2024 Financial Results
From Global Medical REIT Inc.
Via Business Wire

Performance

YTD
-15.55%
-15.55%
1 Month
-3.63%
-3.63%
3 Month
+6.05%
+6.05%
6 Month
-1.69%
-1.69%
1 Year
+1.86%
+1.86%

More News

Read More
Global Medical REIT Inc. Announces Dates for Second Quarter Earnings Release and Webcast
From Global Medical REIT Inc.
Via Business Wire
Global Medical REIT Inc. Releases Corporate Social Responsibility Report
From Global Medical REIT Inc.
Via Business Wire
Global Medical REIT: Dividend Insights
Via Benzinga
Earnings Scheduled For February 27, 2024
Via Benzinga
Monday Is Your Last Chance To Buy Global Medical REIT Before The Dividend Payout
Via Benzinga
Global Medical REIT Inc. Board Declares 2024 Second Quarter Common and Preferred Dividends
From Global Medical REIT Inc.
Via Business Wire
GMRE Stock Earnings: Global Medical REIT Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Global Medical REIT Announces First Quarter 2024 Financial Results
From Global Medical REIT Inc.
Via Business Wire
Global Medical REIT Inc. Announces Dates for First Quarter Earnings Release and Webcast
From Global Medical REIT Inc.
Via Business Wire
Earnings Scheduled For November 6, 2023
Via Benzinga
Global Medical REIT Inc. Board Declares 2024 First Quarter Common and Preferred Dividends
From Global Medical REIT Inc.
Via Business Wire
Global Medical REIT Announces Fourth Quarter and Year-End 2023 Financial Results
From Global Medical REIT Inc.
Via Business Wire
Global Medical REIT Inc. Announces Dates for 2023 Fourth Quarter and Year-End Earnings Release and Webcast
From Global Medical REIT Inc.
Via Business Wire
Global Medical REIT Reports Tax Treatment of 2023 Dividends
From Global Medical REIT Inc.
Via Business Wire
Achieving Growth and Investor Rewards: Global Medical REIT Flourishes with Strong Performance and Rising Profits
Via Benzinga
Global Medical REIT Inc. Board Declares 2023 Fourth Quarter Common and Preferred Dividends
From Global Medical REIT Inc.
Via Business Wire
Global Medical REIT Announces Third Quarter 2023 Financial Results
From Global Medical REIT Inc.
Via Business Wire
Global Medical REIT Inc. Announces Dates for Third Quarter Earnings Release and Webcast
From Global Medical REIT Inc.
Via Business Wire
Global Medical REIT Inc. Board Declares 2023 Third Quarter Common and Preferred Dividends
From Global Medical REIT Inc.
Via Business Wire
Global Medical REIT Announces Second Quarter 2023 Financial Results
From Global Medical REIT Inc.
Via Business Wire
Check Out 3 Real Estate Stocks With Over 6% Dividend Yields From Wall Street's Most Accurate Analysts
Via Benzinga
Global Medical REIT Inc. Announces Dates for Second Quarter Earnings Release and Webcast
From Global Medical REIT Inc.
Via Business Wire
Check Out 3 High-Yielding Dividend Stocks In Real Estate Sector From Wall Street's Most Accurate Analysts
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.